The antibody-based CA125-targeted maintenance therapy for the epithelial ovarian cancer: a meta-analysis.
CONCLUSIONS: CA125-targeted antibody used as maintenance therapy alone is not more effective than placebo but they were safe as maintenance therapy.
PMID: 29894066 [PubMed - in process]
Source: European Journal of Gynaecological Oncology - Category: OBGYN Tags: Eur J Gynaecol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Epithelial Cancer | OBGYN | Ovarian Cancer | Ovaries | Toxicology | Women